A hard look at angiotensin receptor blockers in heart failure

This publication has 21 references indexed in Scilit:

• Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure
  Journal of the American College of Cardiology, 2002
• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure
  Published by Oxford University Press (OUP) ,2000
• Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
  Circulation, 1999
• Long-term survival in severe heart failure in patients treated with enalapril; ten year follow-up of CONSENSUS I
  European Heart Journal, 1999
• Aldosterone escape during ACE inhibitor therapy in chronic heart failure
  European Heart Journal, 1995
• The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.
  Proceedings of the National Academy of Sciences, 1995
• Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
  Circulation Research, 1991
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• Angiotensin II-forming pathways in normal and failing human hearts.
  Circulation Research, 1990